Axovant Sciences Ltd (NASDAQ: AXON) is having an incredibly strong start to the trading session this morning after the company announced news with regard to restructuring. Ultimately, the company plans on pipeline expansion, leading to excitement among investors and sending the stock on a run for the top. Today, we’ll talk about: The news; what … Read more
Allergan Rg (NYSE: AGN) is having a relatively rough start to the trading session this morning. However, the stock really should be headed up. After all, the company produced an earnings report that beat expectations on both the top and bottom line. As always, our partners at Trade Ideas were the first to alert us … Read more
Pernix Therapeutics Holdings Inc (NASDAQ: PTX) is off to an overwhelmingly strong start in the market today, and for good reason. It all has to do with a suit that was filed against the company’s larger competitors. Of course, this led to excitement among investors and gains in the stock. As is almost always the … Read more
Paratek Pharmaceuticals Inc (NASDAQ: PRTK) | Allergan Rg (NYSE: AGN) Paratek Pharmaceuticals is having an incredibly strong start in the pre-market hours today, and for good reason. The company is gaining as the result of excitement surrounding a study the company is working on in collaboration with Allergan. In a press release issued this morning, … Read more
Zeltiq Aesthetics Inc (NASDAQ: ZLTQ) Zeltiq Aesthetics is having an incredibly strong start to today’s trading session. Thanks to strong pre-market gains, the stock started the day off with an impressive profit. While we’re still early in the first hour, it’s clear that the stock is going to close the day well into the green. … Read more
Allergan (NYSE: AGN) Allergan was already off to a rough day in the market today, and for good reason. The company released its earnings report for the most recent quarter, and the report wasn’t positive. However, minutes ago, we started to notice a spike further down. Below, we’ll talk about what we’re seeing, why, and … Read more
Synergy Pharmaceuticals Inc (NASDAQ: SGYP) Synergy Pharmaceuticals is having an incredible day in the market today, as chatter with regard to a coming takeover is reborn. The big question is: Will a takeover happen? While this question is still yet to be answered, I believe that regardless of takeover possibilities, the stock is screaming “BUY … Read more
Allergan (NYSE: AGN) Allergan is having an incredibly hard day in the market today, and for good reason. The company is the center of actions made by the U.S. Treasury as well as the IRS. Today, we’ll talk about those actions, why they are hitting AGN so hard, and what we can expect to see … Read more
Allergan (NYSE: AGN) Allergan is having a strong start in the market today, and for good reason. The company recently reported earnings for the fourth quarter of 2015, beating expectations. Today, we’ll take a look at the earnings report, how the market reacted to the news, and what we can expect to see moving from … Read more
Pfizer (NYSE:PFE) & Allergan (NASDAQ:AGN) On November 23, 2015 big pharma giant Pfizer announced that it had set a deal to merge with another pharmaceutical company known as Allergan. The deal totals about $160 billion, and ends up being $363 per Allergan Share. The combined company is expected to keep the Pfizer tickers symbol “PFE” … Read more